中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

辅助性T淋巴细胞9在慢性丙型肝炎初治患者中的变化及临床意义

王姣 田元元 梁志军

引用本文:
Citation:

辅助性T淋巴细胞9在慢性丙型肝炎初治患者中的变化及临床意义

DOI: 10.3969/j.issn.1001-5256.2020.12.013
基金项目: 

海南省卫生计生行业科研项目(19A200098); 

详细信息
  • 中图分类号: R512.63

Change and clinical significance of T helper 9 cells in previously untreated patients with chronic hepatitis C

Research funding: 

 

  • 摘要:

    目的观察辅助性T淋巴细胞9(Th9)、IL-9及相关转录因子在慢性丙型肝炎初治患者中的变化,评估与临床指标的相关性。方法选取2018年12月-2019年7月于海南省人民医院就诊的慢性丙型肝炎初治患者29例和健康对照者15例,慢性丙型肝炎患者接受索磷布韦/维帕他韦抗病毒治疗12周,分离血浆和外周血单个核细胞(PBMC)。流式细胞术检测PBMC中CD3+CD4+IL-9+的Th9比例,ELISA检测血浆中IL-9水平,实时定量PCR法检测PBMC中IL-9和转录因子PU. 1、Foxo1的mRNA相对表达量。两组间比较采用t检验或配对t检验,采用Pearson检验进行相关性分析。结果慢性丙型肝炎初治患者外周血Th9比例明显低于健康对照者(0. 92%±0. 14%vs 1. 14%±0. 21%,t=4. 31,P<0. 001),血浆IL-9水平亦明显低于健康对照者[(248. 27±66. 97) pg/ml vs (309. 02±88. 48) pg/ml,t=2. 63,P=0. 012]。慢性丙型肝炎初治患者PBMC中IL-9和PU. 1 mRNA相对表达量均明显低于健...

     

  • [1] HE Y,DONG L,CAO Y,et al. IL-9 and Th9 cells in tumor immunity[J]. Adv Exp Med Biol,2020,1240:35-46.
    [2] MALIK S,SADHU S,ELESELA S,et al. Transcription factor Foxo1 is essential for IL-9 induction in T helper cells[J]. Nat Commun,2017,8(1):815.
    [3] ORLOVA-FINK N,CHOWDHURY FZ,SUN X,et al. Preferential susceptibility of Th9 and Th2 CD4+T cells to X4-tropic HIV-1 infection[J]. AIDS,2017,31(16):2211-2215.
    [4] KAPLAN MH,HUFFORD MM,OLSON MR. The development and in vivo function of T helper 9 cells[J]. Nat Rev Immunol,2015,15(5):295-307.
    [5] NEURATH MF,KAPLAN MH. Th9 cells in immunity and immunopathological diseases[J]. Semin Immunopathol,2017,39(1):1-4.
    [6] TAPPE D,PREZ-GIRN JV,ZAMMARCHI L,et al. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase[J]. Med Microbiol Immunol,2016,205(3):269-273.
    [7] AZEVEDO R,de SOUSA JR,ARAUJO M,et al. In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus[J].Sci Rep,2018,8(1):1.
    [8] GORENEC L,ZIDOVEC LEPEJ S,GRGIC I,et al. The comparison of Th1,Th2,Th9,Th17 and Th22 cytokine profiles in acute and chronic HIV-1 infection[J]. Microb Pathog,2016,97:125-130.
    [9] CUI M,LV Y,LU J,et al. Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection[J]. J Clin Lab Anal,2018,32(2):e22246.
    [10] BUTTRICK TS,WANG W,YUNG C,et al. Foxo1 promotes Th9 cell differentiation and airway allergy[J]. Sci Rep,2018,8(1):818.
    [11] MALIK S,AWASTHI A. Transcriptional control of Th9 cells:Role of Foxo1 in interleukin-9 induction[J]. Front Immunol,2018,9:995.
    [12] CASEY JL,FELD JJ,MACPARLAND SA. Restoration of HCV-specific immune responses with antiviral therapy:A case for DAA treatment in acute HCV infection[J]. Cells,2019,8(4):317.
    [13] SANTANGELO L,BORDONI V,MONTALDO C,et al. Hepatitis C virus direct-acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties[J]. Liver Int,2018,38(10):1741-1750.
    [14] GAO Y,LIANG ZJ,FU J. Influence of sofosbuvir-based antiviral therapy on the expression profile of cytokines and chemokines in patients with chronic hepatitis C[J]. J Clin Hepatol,2019,35(10):2200-2204.(in Chinese)高艺,梁志军,符健.以索磷布韦为基础的治疗方案对慢性丙型肝炎患者细胞因子/趋化因子表达谱的影响[J].临床肝胆病杂志,2019,35(10):2200-2204.
    [15] YAN H,ZHANG X,LV Y. The effect of entecavir therapy on immune status in chronic hepatitis B patients[J]. Iran J Immunol,2019,16(1):84-91.
  • 加载中
计量
  • 文章访问数:  4468
  • HTML全文浏览量:  57
  • PDF下载量:  67
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-05-14
  • 出版日期:  2020-12-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回